WO2008129802A1 - 血清尿酸値低下剤および血清尿酸値を低下させる旨の表示を付した飲食品 - Google Patents

血清尿酸値低下剤および血清尿酸値を低下させる旨の表示を付した飲食品 Download PDF

Info

Publication number
WO2008129802A1
WO2008129802A1 PCT/JP2008/000657 JP2008000657W WO2008129802A1 WO 2008129802 A1 WO2008129802 A1 WO 2008129802A1 JP 2008000657 W JP2008000657 W JP 2008000657W WO 2008129802 A1 WO2008129802 A1 WO 2008129802A1
Authority
WO
WIPO (PCT)
Prior art keywords
uric acid
acid level
serum uric
drink
food
Prior art date
Application number
PCT/JP2008/000657
Other languages
English (en)
French (fr)
Inventor
Toshiro Omori
Hideki Hokazono
Original Assignee
Sanwa Shurui Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Shurui Co., Ltd. filed Critical Sanwa Shurui Co., Ltd.
Priority to JP2009510765A priority Critical patent/JP5044643B2/ja
Priority to US12/532,034 priority patent/US8231911B2/en
Publication of WO2008129802A1 publication Critical patent/WO2008129802A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)

Abstract

課題：安全性に問題がなく、これまで廃棄処分されてきた材料である大麦焼酎蒸留残渣から、煩雑な精製工程を経ず、工場規模での実生産に適した簡便な処理方法により、人の血清中の尿酸値を低下させる作用を有する組成物を提供すること。 解決手段：大麦を発酵に付したもの由来の成分、好ましくは大麦焼酎蒸留残渣、または大麦焼酎蒸留残渣を固液分離した液体分（大麦焼酎蒸留残液）および／または該大麦焼酎蒸留残液を分画して得られた組成物を有効成分とする、血清尿酸値低下剤、好ましくは血清尿酸値を低下させるべき疾患の予防または治療用薬剤。上記の血清尿酸値低下剤を含有する、飲食品、医薬品・医薬部外品または飼料の形態の組成物。大麦を発酵に付したもの由来の成分を含有し、血清尿酸値を低下させるべき疾患の予防のために用いられるものである旨の表示を付した飲食品、好ましくは血清尿酸値を低下させるための、機能性飲食品、栄養補助飲食品または健康飲食品。
PCT/JP2008/000657 2007-03-20 2008-03-19 血清尿酸値低下剤および血清尿酸値を低下させる旨の表示を付した飲食品 WO2008129802A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009510765A JP5044643B2 (ja) 2007-03-20 2008-03-19 血清尿酸値低下剤および血清尿酸値を低下させる旨の表示を付した飲食品
US12/532,034 US8231911B2 (en) 2007-03-20 2008-03-19 Serum uric acid level-decreasing agent and food and drink with label telling that food and drink decrease serum uric acid level

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-073231 2007-03-20
JP2007073231 2007-03-20

Publications (1)

Publication Number Publication Date
WO2008129802A1 true WO2008129802A1 (ja) 2008-10-30

Family

ID=39875336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/000657 WO2008129802A1 (ja) 2007-03-20 2008-03-19 血清尿酸値低下剤および血清尿酸値を低下させる旨の表示を付した飲食品

Country Status (3)

Country Link
US (1) US8231911B2 (ja)
JP (1) JP5044643B2 (ja)
WO (1) WO2008129802A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013213021A (ja) * 2012-03-08 2013-10-17 Up Well:Kk 抗糖化剤
WO2016002757A1 (ja) * 2014-06-30 2016-01-07 株式会社明治 プリン体吸収を抑制する乳酸菌及びその用途
WO2017038799A1 (ja) * 2015-09-04 2017-03-09 サントリーホールディングス株式会社 ウレアーゼ活性阻害剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9441210B2 (en) 2013-06-26 2016-09-13 Food Industry Research And Development Institute Method of reducing levels of uric acid

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05238943A (ja) * 1992-02-28 1993-09-17 Yoshihide Hagiwara キサンチンオキシダーゼ阻害剤
JP2003038158A (ja) * 2001-03-06 2003-02-12 Sanwa Shiyurui Kk 大麦焼酎蒸留残液から分取した肝障害発症抑制作用を有する精製濃縮物及び該精製濃縮物の製造方法
WO2004112809A1 (ja) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. 血清尿酸低減組成物
JP2005281159A (ja) * 2004-03-29 2005-10-13 Sanwa Shiyurui Kk 大麦焼酎蒸留残液から得られる血圧降下作用を有する組成物
JP2006001902A (ja) * 2004-06-18 2006-01-05 Oto Corporation:Kk 抗腫瘍物質、これを用いた飲食品及び抗腫瘍物質の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3495429B2 (ja) 1994-08-24 2004-02-09 三和酒類株式会社 焼酎粕から得られる飼料の製造方法
JP3405956B2 (ja) 2000-03-24 2003-05-12 株式会社ファンケル 食品組成物
JP3768795B2 (ja) 2000-10-16 2006-04-19 株式会社ファンケル キサンチンオキシダーゼ阻害剤
DE10296423T8 (de) 2001-03-02 2004-07-08 William Marsh Rice University, Houston Mittles elektrischem Potential unterstützter Aufbau von molekularen Vorrichtungen
US20070297216A1 (en) 2001-03-02 2007-12-27 William Marsh Rice University Self-assembly of molecular devices
US20070128744A1 (en) 2005-07-27 2007-06-07 Tour James M Self-assembly of molecules and nanotubes and/or nanowires in nanocell computing devices, and methods for programming same
JP2003252776A (ja) 2002-02-27 2003-09-10 Wakunaga Pharmaceut Co Ltd キサンチンオキシダーゼ阻害剤
JP4527356B2 (ja) 2003-02-05 2010-08-18 三和酒類株式会社 抗酸化作用を有する組成物からなる抗酸化剤
JP4524342B2 (ja) 2003-06-05 2010-08-18 三和酒類株式会社 大麦焼酎蒸留残液から分取した記憶学習能向上の薬理作用を呈する組成物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05238943A (ja) * 1992-02-28 1993-09-17 Yoshihide Hagiwara キサンチンオキシダーゼ阻害剤
JP2003038158A (ja) * 2001-03-06 2003-02-12 Sanwa Shiyurui Kk 大麦焼酎蒸留残液から分取した肝障害発症抑制作用を有する精製濃縮物及び該精製濃縮物の製造方法
WO2004112809A1 (ja) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. 血清尿酸低減組成物
JP2005281159A (ja) * 2004-03-29 2005-10-13 Sanwa Shiyurui Kk 大麦焼酎蒸留残液から得られる血圧降下作用を有する組成物
JP2006001902A (ja) * 2004-06-18 2006-01-05 Oto Corporation:Kk 抗腫瘍物質、これを用いた飲食品及び抗腫瘍物質の製造方法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013213021A (ja) * 2012-03-08 2013-10-17 Up Well:Kk 抗糖化剤
WO2016002757A1 (ja) * 2014-06-30 2016-01-07 株式会社明治 プリン体吸収を抑制する乳酸菌及びその用途
JPWO2016002757A1 (ja) * 2014-06-30 2017-04-27 株式会社明治 プリン体吸収を抑制する乳酸菌及びその用途
WO2017038799A1 (ja) * 2015-09-04 2017-03-09 サントリーホールディングス株式会社 ウレアーゼ活性阻害剤
JPWO2017038799A1 (ja) * 2015-09-04 2018-07-12 サントリーホールディングス株式会社 ウレアーゼ活性阻害剤

Also Published As

Publication number Publication date
US8231911B2 (en) 2012-07-31
JPWO2008129802A1 (ja) 2010-07-22
US20100151063A1 (en) 2010-06-17
JP5044643B2 (ja) 2012-10-10

Similar Documents

Publication Publication Date Title
PH12020500521A1 (en) Fruit extracts
WO2017208217A2 (en) C5 ketone compositions, and related methods, for therapeutic and performance supplementation
WO2007087250A3 (en) Tricyclic inhibitors of 5-lipoxygenase
WO2010135530A3 (en) Compounds, compositions and methods for modulating uric acid levels
WO2008129802A1 (ja) 血清尿酸値低下剤および血清尿酸値を低下させる旨の表示を付した飲食品
WO2010083207A3 (en) Protein kinase c inhibitors and uses thereof
DE602006019467D1 (de) Nahrungsmittel-emulsion für riegel, füllungen, beschichtungen und aufstriche, sowie verfahren zu ihrer herstellung
CN105400653B (zh) 一种两次发酵法制备茶酒的方法
EP1949792A3 (en) The healthy and functional foods for the obesity patients using purple-colored potato
WO2011000808A3 (de) Verfahren der abtrennung von acrylsäure aus dem produktgasgemisch einer heterogen katalysierten partiellen gasphasenoxidation wenigstens einer c3-vorläuferverbindung
WO2007098142A3 (en) Oxazole ketones as modulators of fatty acid amide hydrolase
JP2012524028A5 (ja)
WO2007148341A3 (en) Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
TW200508210A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
WO2005123651A8 (en) L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF
JP6663993B2 (ja) 安定性が向上し、取り込みが改善されたホノキオール及びマグノロール製剤、並びにそれらの使用方法
WO2010089874A1 (ja) ＰＰＡＲ－γ発現増強剤、アディポネクチン産生促進剤、ＵＣＰ活性剤およびそれらを用いた医薬品・飲食品
JP6715587B2 (ja) アセトアルデヒド除去剤
WO2012154009A3 (ko) 티에노피리미딘 유도체， 이의 약학적으로 허용가능한 이의 제조방법 및 이를 유효성분으로 함유하는 당뇨 관련 질환의 또는 치료용 약학적 조성물
Awad et al. Ameliorative Effect of Some Medicinal Plants Against Experimentally Hyperuricemic Rats
WO2009109973A3 (en) Compounds and methods of treating obesity
TW200738654A (en) Alkoxymethyl-substituted benzoic acid derivatives, process for their preparation and their use as medicaments
CN101503411B (zh) 一种芝麻油中芝麻素的分离方法
WO2014178081A3 (en) Molecular traps for certain undesirable materials
JP2006022036A (ja) 脳の処理機能を効率化させる作用を有する香気組成物、およびその利用

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08720542

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2009510765

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 12532034

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 08720542

Country of ref document: EP

Kind code of ref document: A1